Cytology and High-Risk Human Papillomavirus Test for Cervical Cancer Screening Assessment

Background: A new nationwide screening strategy was implemented in Germany in January 2020. No data are available for women referred to certified dysplasia units for secondary clarification after primary diagnosis by a local physician. We therefore investigated combined testing with Papanicolaou sme...

Descripción completa

Detalles Bibliográficos
Autores principales: Stuebs, Frederik A., Koch, Martin C., Dietl, Anna K., Adler, Werner, Geppert, Carol, Hartmann, Arndt, Knöll, Antje, Beckmann, Matthias W., Mehlhorn, Grit, Schulmeyer, Carla E., Gass, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318141/
https://www.ncbi.nlm.nih.gov/pubmed/35885651
http://dx.doi.org/10.3390/diagnostics12071748

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318141/
https://www.ncbi.nlm.nih.gov/pubmed/35885651
http://dx.doi.org/10.3390/diagnostics12071748

Ejemplares similares